1. Home
  2. SGA vs CASI Comparison

SGA vs CASI Comparison

Compare SGA & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGA
  • CASI
  • Stock Information
  • Founded
  • SGA 1986
  • CASI 1991
  • Country
  • SGA United States
  • CASI China
  • Employees
  • SGA N/A
  • CASI N/A
  • Industry
  • SGA Broadcasting
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • SGA Consumer Discretionary
  • CASI Health Care
  • Exchange
  • SGA Nasdaq
  • CASI Nasdaq
  • Market Cap
  • SGA 72.0M
  • CASI 58.8M
  • IPO Year
  • SGA 1992
  • CASI 1996
  • Fundamental
  • Price
  • SGA $12.03
  • CASI $2.63
  • Analyst Decision
  • SGA
  • CASI Strong Buy
  • Analyst Count
  • SGA 0
  • CASI 1
  • Target Price
  • SGA N/A
  • CASI $6.00
  • AVG Volume (30 Days)
  • SGA 40.6K
  • CASI 42.2K
  • Earning Date
  • SGA 03-06-2025
  • CASI 11-15-2024
  • Dividend Yield
  • SGA 8.18%
  • CASI N/A
  • EPS Growth
  • SGA N/A
  • CASI N/A
  • EPS
  • SGA 0.75
  • CASI N/A
  • Revenue
  • SGA $110,669,000.00
  • CASI $22,055,000.00
  • Revenue This Year
  • SGA N/A
  • CASI N/A
  • Revenue Next Year
  • SGA $2.64
  • CASI $134.79
  • P/E Ratio
  • SGA $16.28
  • CASI N/A
  • Revenue Growth
  • SGA N/A
  • CASI N/A
  • 52 Week Low
  • SGA $10.75
  • CASI $2.05
  • 52 Week High
  • SGA $24.70
  • CASI $8.19
  • Technical
  • Relative Strength Index (RSI)
  • SGA 53.31
  • CASI 38.88
  • Support Level
  • SGA $11.57
  • CASI $2.44
  • Resistance Level
  • SGA $12.00
  • CASI $2.76
  • Average True Range (ATR)
  • SGA 0.40
  • CASI 0.30
  • MACD
  • SGA 0.11
  • CASI 0.04
  • Stochastic Oscillator
  • SGA 85.37
  • CASI 22.35

About SGA Saga Communications Inc. (FL)

Saga Communications Inc is a broadcast company engaged in acquiring, developing, and operating broadcast properties. The company's objective is to operate top billing radio stations in mid-sized markets and It derives a majority of its revenue from the sale of advertising for broadcast on its stations.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: